biocheckinc.com - About the company
biocheckinc.com is an acquired company based in Foster City (United States), founded in 1997 by John Chen. It operates as a Diagnostic immunoassay devices for biomedical, pharmaceutical, and scientific research markets. The company has 280 active competitors, including 16 funded and 39 that have exited. Its top competitors include companies like Sino Biological, GenScript and Pixelgen Technolgies.
Company Details
Diagnostic immunoassay devices for biomedical, pharmaceutical, and scientific research markets. We design, develop, and manufacture high-quality in vitro diagnostic immunoassay devices. Our product categories include tumor markers, cardiac markers, steroids, infectious diseases, thyroids, and fertility solutions. We also offer antibody purification and conjugation services. We are committed to providing quality products and best-in-class customer care. Our goal is to provide timely information so treatment can be implemented earlier and effectiveness can be analyzed sooner, to better long-term outcomes and improve lives. We provide innovative immunoassay devices for better health outcomes worldwide. We are ISO certified and compliant. We offer login, cart, and subscription services. Our products support research needs with instruments, antibodies, and ELISA kits, all rigorously tested and designed to meet the highest standards of quality and specificity.
- Website
- biocheckinc.com
- Email ID
- *****@biocheckinc.com
Key Metrics
Founded Year
1997
Location
Foster City, United States
Stage
Acquired
Ranked
32nd among 280 active competitors
Employee Count
21 as on Sep 30, 2026
Investment & Acquisitions
Similar Companies
Exit Details
Acquired by OriGene (Feb 26, 2014)
Legal entities associated with biocheckinc.com
biocheckinc.com is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
Biocheck, Inc. CIN: 943256633 , United States, Active | Dec 31, 1999 | - | 27 (As on Dec 31, 2024) | - |
biocheckinc.com's acquisition details
biocheckinc.com got acquired by OriGene on Feb 26, 2014.
Click here to take a look at biocheckinc.com's acquisition in detail
Sign up to download biocheckinc.com's company profile
biocheckinc.com's funding and investors
biocheckinc.com is a funded company.
biocheckinc.com's founders and board of directors
Founder? Claim ProfileThe founders of biocheckinc.com is John Chen.
Here are the details of biocheckinc.com's key team members:
- John Chen: Founder & CEO of biocheckinc.com.
View details of biocheckinc.com's Founder profiles and Board Members
biocheckinc.com's employee count trend
biocheckinc.com has 21 employees as of Sep 26. Here is biocheckinc.com's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
biocheckinc.com's Competitors and alternates
Top competitors of biocheckinc.com include Sino Biological, GenScript and Pixelgen Technolgies. Here is the list of Top 10 competitors of biocheckinc.com, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Sino Biological 2007, Beijing (China), Series A | Provider of reagents,and kits for clinical research | $29.4M | 63/100 | |
2nd | GenScript 2002, Piscataway (United States), Public | Provider of reagents and instruments for life sciences research | $15M | 55/100 | |
3rd | Pixelgen Technolgies 2020, Stockholm (Sweden), Series B | Developer of ground-breaking technologies for biomedical research and diagnostics | $21.5M | 55/100 | |
4th | Shanghai OPM Biosciences 2013, Pudong (China), Series B | Antibody culture media and vaccine culture products developer | $14.4M | 54/100 | |
5th | Develops antibodies and ELISA kits | - | 53/100 | ||
6th | Developer of monoclonal antibodies to prevent transplant rejections | $87M | 51/100 | ||
7th | Immuno-Biological Laboratories 1982, Fujioka (Japan), Public | Manufacture antibodies | - | 49/100 | |
8th | GeneTex is a manufacturer and supplier of bioreagents for life science research. | $4.3M | - | 49/100 | |
9th | Antibodies.com 2015, Cambridge (United Kingdom), Seed | Provider of portfolio of diagnostic reagents | $506K | 49/100 | |
10th | Allele Biotech 1999, San Diego (United States), Series B | cGMP iPSCs and cell therapy CDMO accelerating regenerative medicine programs | $18M | 48/100 | |
32nd | biocheckinc.com 1997, Foster City (United States), Acquired | Diagnostic immunoassay devices for biomedical, pharmaceutical, and scientific research markets | - | - | 31/100 |
Looking for more details on biocheckinc.com's competitors? Click here to see the top ones
biocheckinc.com's Investments and acquisitions
biocheckinc.com has acquired DRG International. biocheckinc.com has not made any investments as of now.Reports related to biocheckinc.com
Here is the latest report on biocheckinc.com's sector:
News related to biocheckinc.com
•
BioCheck Inc to acquire DRG International Inc, a leading IVD companyPR Newswire•Aug 19, 2021•biocheckinc.com, DRG International, PerkinElmer
•
Accelerate Diagnostics, BioCheck Receive FDA Emergency Use Authorization for SARS-CoV-2 Antibody Tests360Dx•Sep 10, 2020•Accelerate Diagnostics, biocheckinc.com
•
Accelerate Diagnostics Announces FDA Emergency Use Authorization for COVID-19 Antibody Testing SystemPR Newswire•Aug 18, 2020•Accelerate Diagnostics, biocheckinc.com
•
Are you a Founder ?
FAQs about biocheckinc.com
Explore our recently published companies
- John Mattone Intelligent Leadership Certified Coach - Orlando based, 2010 founded, Unfunded company
- Tyson - Unfunded company
- Wolters Consulting - San Jose based, Unfunded company
- The Ragan - San Antonio based, 2022 founded, Unfunded company
- Dragonfly Consultants - Unfunded company
- Dotizo Advertising - United Arab Emirates based, 2022 founded, Unfunded company